- Home
- MRK vs TXN Comparison
MRK vs TXN Comparison
Compare MRK & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | TXN |
|---|---|---|
| Founded | 2000 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 259.1B |
| IPO Year | 1997 | 2002 |
Fundamental Metrics
Financial Performance| Metric | MRK | TXN |
|---|---|---|
| Price | $150.04 | $298.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 35 |
| Target Price | $159.60 | ★ $336.86 |
| AVG Volume (30 Days) | ★ 7.2M | 5.8M |
| Earning Date | 10-29-2026 | 10-21-2026 |
| Dividend Yield | ★ 2.32% | 1.94% |
| EPS Growth | ★ 8.01 | 4.81 |
| EPS | N/A | ★ 6.44 |
| Revenue | ★ $65,011,000,000.00 | $17,682,000,000.00 |
| Revenue This Year | $3.36 | $26.68 |
| Revenue Next Year | $3.85 | $17.16 |
| P/E Ratio | ★ N/A | $48.41 |
| Revenue Growth | 1.31 | ★ 13.05 |
| 52 Week Low | $82.01 | $152.73 |
| 52 Week High | $157.00 | $334.03 |
Technical Indicators
Market Signals| Indicator | MRK | TXN |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 58.13 |
| Support Level | $145.75 | $271.60 |
| Resistance Level | $154.35 | $312.81 |
| Average True Range (ATR) | 4.60 | 10.01 |
| MACD | 0.12 | 2.18 |
| Stochastic Oscillator | 68.13 | 64.93 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.